Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.
Abbott Laboratories (ABT) shares rose 4.07% to $87.91 on a mixed trading day, outperforming competitors like Johnson & Johnson (JNJ) and Merck (MRK). Despite the gain, Abbott's stock remains 36.78% below its 52-week high of $139.06. The Dow Jones increased by 0.32%, while the S&P 500 fell by 0.07%. Trading volume was below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments